<DOC>
	<DOC>NCT01391286</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of bimatoprost solution 0.03% compared with vehicle in Japanese adults with hypotrichosis of the eyelashes following chemotherapy treatment.</brief_summary>
	<brief_title>Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis</brief_title>
	<detailed_description />
	<mesh_term>Hypotrichosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>Have inadequate eyelashes due to chemotherapy treatment Treated for solid tumors such as breast or colorectal cancer in early stages where the cancer has not spread outside the primary organ (eg, stage 1, 2 or 3a for breast cancer) Have completed chemotherapy treatment for at least 4 weeks but not more than 24 weeks and all side effects related to chemotherapy are recovered, improved or maintained, with the exception of hair loss Any disease/infection/abnormality of the eye or area around the eye Any ocular surgery within 3 months or anticipated need for ocular surgery during the study Any permanent eyeliner or implants of any kind or anticipated use of false eyelashes Any semipermanent eyelash tint, dye, curl or eyelash extension application within 3 months Use of any overthecounter eyelash growth product within 6 months or any use of prescription eyelash growth products Use of treatments which may affect hair growth (eg, minoxidil) within 6 months except for prior chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>